comparemela.com

Latest Breaking News On - உயர் மயோபியா - Page 1 : comparemela.com

Chinese Multinational Technology Company, HUAWEI, Aligns With Singapore-Based Healthtech Start-up PLANO to Tackle the Global Problem of Myopia

Johnson & Johnson Vision Announces FDA Approval of ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management

Thomson X Inks Strategic Partnership with Singapore-Based Startup Plano and Set Sights on Managing Myopia in Asia

TX ), a wholly-owned subsidiary of SGX Mainboard-listed Thomson Medical Group Limited (the Group ), today announced a strategic partnership with Plano Pte Ltd ( Plano ), a Singapore-based HealthTech startup. The collaboration will leverage on the respective strengths of TX and Plano to address and manage the rapidly increasing incidence of myopia through innovative technological solutions. Myopia is steadily growing into one of the biggest public health challenges in the world, affecting an estimated 2.6 billion people globally, or about one-third of the world s population. By 2050, myopia is projected to affect 5 billion people, which is estimated to be about half of the world s population

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.